First Time Loading...

Heidelberg Pharma AG
XETRA:HPHA

Watchlist Manager
Heidelberg Pharma AG Logo
Heidelberg Pharma AG
XETRA:HPHA
Watchlist
Price: 2.98 EUR Market Closed
Updated: May 6, 2024

Heidelberg Pharma AG
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Heidelberg Pharma AG
Net Income (Common) Peer Comparison

Comparables:
BNTX
MOR
IMTX
BIO
FYB

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Heidelberg Pharma AG
XETRA:HPHA
Net Income (Common)
-€20.3m
CAGR 3-Years
-3%
CAGR 5-Years
-12%
CAGR 10-Years
N/A
BioNTech SE
NASDAQ:BNTX
Net Income (Common)
€930.3m
CAGR 3-Years
296%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
MorphoSys AG
XETRA:MOR
Net Income (Common)
-€189.7m
CAGR 3-Years
N/A
CAGR 5-Years
-28%
CAGR 10-Years
N/A
Immatics NV
NASDAQ:IMTX
Net Income (Common)
-€97m
CAGR 3-Years
23%
CAGR 5-Years
-25%
CAGR 10-Years
N/A
Biotest AG
XETRA:BIO
Net Income (Common)
€127m
CAGR 3-Years
N/A
CAGR 5-Years
-7%
CAGR 10-Years
15%
Formycon AG
XETRA:FYB
Net Income (Common)
€36m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Heidelberg Pharma AG's Net Income (Common)?
Net Income (Common)
-20.3m EUR

Based on the financial report for Nov 30, 2023, Heidelberg Pharma AG's Net Income (Common) amounts to -20.3m EUR.

What is Heidelberg Pharma AG's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
-12%

Over the last year, the Net Income (Common) growth was -3%. The average annual Net Income (Common) growth rates for Heidelberg Pharma AG have been -3% over the past three years , -12% over the past five years .